Clinical Trial Update: Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating soy isoflavones in prostate cancer patients undergoing radical prostatectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Soy Isoflavones (isoflavones from soy)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED